$AMED
AMEDISYS INC

2018 Q2 Form 10-Q Financial Statement

#000089626218000008 Filed on August 01, 2018

View on sec.gov

Income Statement

Concept 2018 Q2 2017 Q2
Revenue $411.6M $374.9M
YoY Change 9.79% 3.94%
Cost Of Revenue $242.6M $220.5M
YoY Change 10.0% 6.8%
Gross Profit $169.0M $154.4M
YoY Change 9.46% 0.13%
Gross Profit Margin 41.06% 41.18%
Selling, General & Admin $123.1M $120.9M
YoY Change 1.82% -7.64%
% of Gross Profit 72.84% 78.3%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.100M $4.600M
YoY Change -32.61% -6.12%
% of Gross Profit 1.83% 2.98%
Operating Expenses $126.2M $125.5M
YoY Change 0.56% -7.65%
Operating Profit $42.80M $240.0K
YoY Change 17733.33% -98.69%
Interest Expense $2.140M $1.197M
YoY Change 78.78% -233.0%
% of Operating Profit 5.0% 498.75%
Other Income/Expense, Net $1.309M $2.326M
YoY Change -43.72% 232.29%
Pretax Income $44.14M $2.566M
YoY Change 1620.07% -85.81%
Income Tax $10.60M -$1.963M
% Of Pretax Income 24.01% -76.5%
Net Earnings $33.30M $4.500M
YoY Change 640.0% -57.94%
Net Earnings / Revenue 8.09% 1.2%
Basic Earnings Per Share $1.00 $0.13
Diluted Earnings Per Share $0.98 $0.13
COMMON SHARES
Basic Shares Outstanding 33.44M shares 33.64M shares
Diluted Shares Outstanding 34.18M shares 34.33M shares

Balance Sheet

Concept 2018 Q2 2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $25.90M $59.20M
YoY Change -56.25% 492.0%
Cash & Equivalents $25.90M $59.16M
Short-Term Investments
Other Short-Term Assets $24.78M $40.60M
YoY Change -38.96% 134.68%
Inventory
Prepaid Expenses $10.49M
Receivables $197.6M $173.4M
Other Receivables $0.00 $0.00
Total Short-Term Assets $258.8M $273.1M
YoY Change -5.25% 52.14%
LONG-TERM ASSETS
Property, Plant & Equipment $28.00M $34.40M
YoY Change -18.6% -22.87%
Goodwill $324.1M
YoY Change
Intangibles $44.89M
YoY Change
Long-Term Investments
YoY Change
Other Assets $50.60M $139.1M
YoY Change -63.62% -12.46%
Total Long-Term Assets $494.6M $532.8M
YoY Change -7.18% 0.23%
TOTAL ASSETS
Total Short-Term Assets $258.8M $273.1M
Total Long-Term Assets $494.6M $532.8M
Total Assets $753.3M $805.9M
YoY Change -6.52% 13.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $29.81M $29.10M
YoY Change 2.44% -17.09%
Accrued Expenses $96.47M $188.1M
YoY Change -48.71% 25.65%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $700.0K $8.100M
YoY Change -91.36% 62.0%
Total Short-Term Liabilities $214.2M $225.3M
YoY Change -4.93% 18.71%
LONG-TERM LIABILITIES
Long-Term Debt $123.9M $83.20M
YoY Change 48.92% -7.04%
Other Long-Term Liabilities $6.137M $4.300M
YoY Change 42.72% 7.5%
Total Long-Term Liabilities $130.0M $83.20M
YoY Change 56.29% -7.04%
TOTAL LIABILITIES
Total Short-Term Liabilities $214.2M $225.3M
Total Long-Term Liabilities $130.0M $83.20M
Total Liabilities $344.3M $313.8M
YoY Change 9.71% 12.36%
SHAREHOLDERS EQUITY
Retained Earnings $60.71M
YoY Change
Common Stock $585.1M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $237.9M
YoY Change
Treasury Stock Shares 4.243M shares
Shareholders Equity $408.0M $492.1M
YoY Change
Total Liabilities & Shareholders Equity $753.3M $805.9M
YoY Change -6.52% 13.33%

Cashflow Statement

Concept 2018 Q2 2017 Q2
OPERATING ACTIVITIES
Net Income $33.30M $4.500M
YoY Change 640.0% -57.94%
Depreciation, Depletion And Amortization $3.100M $4.600M
YoY Change -32.61% -6.12%
Cash From Operating Activities $50.70M $36.20M
YoY Change 40.06% 146.26%
INVESTING ACTIVITIES
Capital Expenditures -$100.0K -$3.000M
YoY Change -96.67% -6.25%
Acquisitions
YoY Change
Other Investing Activities -$1.800M -$20.20M
YoY Change -91.09% 6633.33%
Cash From Investing Activities -$2.000M -$23.20M
YoY Change -91.38% 544.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -142.8M -2.100M
YoY Change 6700.0% -76.4%
NET CHANGE
Cash From Operating Activities 50.70M 36.20M
Cash From Investing Activities -2.000M -23.20M
Cash From Financing Activities -142.8M -2.100M
Net Change In Cash -94.10M 10.90M
YoY Change -963.3% 395.45%
FREE CASH FLOW
Cash From Operating Activities $50.70M $36.20M
Capital Expenditures -$100.0K -$3.000M
Free Cash Flow $50.80M $39.20M
YoY Change 29.59% 118.99%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q4 amed Accounts Receivable Portion Derived From Medicare
AccountsReceivablePortionDerivedFromMedicare
0.59
CY2018Q2 amed Accounts Receivable Portion Derived From Medicare
AccountsReceivablePortionDerivedFromMedicare
0.56
amed Cash Distribution To Noncontrolling Interest
CashDistributionToNoncontrollingInterest
90000 USD
amed Cash Distribution To Noncontrolling Interest
CashDistributionToNoncontrollingInterest
350000 USD
CY2018Q2 amed Consolidated Interest Coverage Ratio
ConsolidatedInterestCoverageRatio
51.0
CY2014Q2 amed Corporate Integrity Agreement Term
CorporateIntegrityAgreementTerm
P5Y
amed Deferred Debt Issuance Costs Written Off
DeferredDebtIssuanceCostsWrittenOff
0 USD
amed Deferred Debt Issuance Costs Written Off
DeferredDebtIssuanceCostsWrittenOff
38000 USD
amed Episode Of Care As Episodic Based Revenue Duration
EpisodeOfCareAsEpisodicBasedRevenueDuration
P60D
amed First Threshold Of Therapy Services Required
FirstThresholdOfTherapyServicesRequired
6 visit
amed Health Insurance Retention Limit
HealthInsuranceRetentionLimit
1000000 USD
amed Historical Collection Rate From Medicare
HistoricalCollectionRateFromMedicare
0.99
CY2017Q2 amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.99
amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.98
CY2018Q2 amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.99
amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.99
amed Increase Decrease In Securities Class Action Lawsuit Settlement Accrual
IncreaseDecreaseInSecuritiesClassActionLawsuitSettlementAccrual
28712000 USD
amed Increase Decrease In Securities Class Action Lawsuit Settlement Accrual
IncreaseDecreaseInSecuritiesClassActionLawsuitSettlementAccrual
0 USD
amed Low Utilization Payment Adjustment Number Of Visits
LowUtilizationPaymentAdjustmentNumberOfVisits
5 visit
amed Maximum Days To Submit Final Bill From Date Request For Anticipated Payment Was Paid
MaximumDaysToSubmitFinalBillFromDateRequestForAnticipatedPaymentWasPaid
60 day
amed Maximum Days To Submit Final Bill From Start Of Episode
MaximumDaysToSubmitFinalBillFromStartOfEpisode
120 day
CY2018Q2 amed Maximum Percent Ownership For Cost Method Percent
MaximumPercentOwnershipForCostMethodPercent
0.20
CY2018Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
15000 USD
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
568780000 USD
CY2018Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
101128000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
9000000 USD
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
15000 USD
CY2018Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
585137000 USD
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.80
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
370000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
355000 USD
amed Rate Of Request For Anticipated Payment Submitted For Subsequent Episodes Of Care
RateOfRequestForAnticipatedPaymentSubmittedForSubsequentEpisodesOfCare
0.50
CY2018Q2 amed Maximum Percent Ownership For Equity Method Percent
MaximumPercentOwnershipForEquityMethodPercent
0.5
CY2018Q2 amed Minimum Percent Ownership For Controlling Interest Percent
MinimumPercentOwnershipForControllingInterestPercent
0.5
amed Net Service Revenue Episode Payment Rate Duration
NetServiceRevenueEpisodePaymentRateDuration
P60D
CY2017Q2 amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
363000 shares
amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
378000 shares
CY2018Q2 amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
315000 shares
amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
305000 shares
amed Percentage Of Patient Receivables Outstanding
PercentageOfPatientReceivablesOutstanding
0.1
amed Percentage Of Total Reimbursement Of Outlier Payment
PercentageOfTotalReimbursementOfOutlierPayment
0.1
amed Professional Liability Insurance Retention Limit
ProfessionalLiabilityInsuranceRetentionLimit
300000 USD
amed Rate Of Request For Anticipated Payment Submitted For Initial Episode Of Care
RateOfRequestForAnticipatedPaymentSubmittedForInitialEpisodeOfCare
0.60
CY2017Q2 amed Revenue Adjustment To Medicare Revenue
RevenueAdjustmentToMedicareRevenue
5000000 USD
amed Revenue Adjustment To Medicare Revenue
RevenueAdjustmentToMedicareRevenue
8400000 USD
CY2018Q2 amed Revenue Adjustment To Medicare Revenue
RevenueAdjustmentToMedicareRevenue
2500000 USD
amed Revenue Adjustment To Medicare Revenue
RevenueAdjustmentToMedicareRevenue
4200000 USD
amed Second Threshold Of Services Required
SecondThresholdOfServicesRequired
14 visit
CY2017Q2 amed Securities Class Action Lawsuitsettlement
SecuritiesClassActionLawsuitsettlement
28712000 USD
CY2017Q2 amed Securities Class Action Lawsuitsettlement
SecuritiesClassActionLawsuitsettlement
28700000 USD
amed Securities Class Action Lawsuitsettlement
SecuritiesClassActionLawsuitsettlement
28700000 USD
amed Securities Class Action Lawsuitsettlement
SecuritiesClassActionLawsuitsettlement
28712000 USD
CY2018Q2 amed Securities Class Action Lawsuitsettlement
SecuritiesClassActionLawsuitsettlement
0 USD
amed Securities Class Action Lawsuitsettlement
SecuritiesClassActionLawsuitsettlement
0 USD
amed Third Threshold Of Therapy Services Required
ThirdThresholdOfTherapyServicesRequired
20 visit
CY2018Q2 amed Total Leverage Ratio
TotalLeverageRatio
0.8
amed Workers Compensation Insurance Retention Limit
WorkersCompensationInsuranceRetentionLimit
500000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
dei Document Period End Date
DocumentPeriodEndDate
2018-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000896262
CY2018Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
31836002 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
AMEDISYS INC
dei Trading Symbol
TradingSymbol
AMED
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
25384000 USD
CY2018Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
29810000 USD
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
201196000 USD
CY2018Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
197592000 USD
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
89104000 USD
CY2018Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
96472000 USD
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
146814000 USD
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
146800000 USD
CY2018Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
101100000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
88000 shares
CY2017Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
169000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
248000 shares
CY2018Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
57000 shares
CY2017Q4 us-gaap Assets
Assets
813482000 USD
CY2018Q2 us-gaap Assets
Assets
753324000 USD
CY2017Q4 us-gaap Assets Current
AssetsCurrent
311156000 USD
CY2018Q2 us-gaap Assets Current
AssetsCurrent
258773000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30197000 USD
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
59164000 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
86363000 USD
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25904000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
28967000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-60459000 USD
CY2018Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35747134 shares
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36044177 shares
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33964767 shares
CY2018Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31801357 shares
CY2017Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
35000 USD
CY2018Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
36000 USD
CY2017Q2 us-gaap Cost Of Services
CostOfServices
220500000 USD
CY2017Q2 us-gaap Cost Of Services
CostOfServices
220541000 USD
us-gaap Cost Of Services
CostOfServices
436870000 USD
us-gaap Cost Of Services
CostOfServices
436900000 USD
CY2018Q2 us-gaap Cost Of Services
CostOfServices
242564000 USD
CY2018Q2 us-gaap Cost Of Services
CostOfServices
242600000 USD
us-gaap Cost Of Services
CostOfServices
480873000 USD
us-gaap Cost Of Services
CostOfServices
480900000 USD
CY2017Q2 us-gaap Costs And Expenses
CostsAndExpenses
374706000 USD
CY2017Q2 us-gaap Costs And Expenses
CostsAndExpenses
374700000 USD
us-gaap Costs And Expenses
CostsAndExpenses
714202000 USD
us-gaap Costs And Expenses
CostsAndExpenses
714200000 USD
CY2018Q2 us-gaap Costs And Expenses
CostsAndExpenses
368775000 USD
CY2018Q2 us-gaap Costs And Expenses
CostsAndExpenses
368800000 USD
us-gaap Costs And Expenses
CostsAndExpenses
732032000 USD
CY2017Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
90700000 USD
CY2018Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
128500000 USD
CY2018Q2 us-gaap Debt Issuance Costs Line Of Credit Arrangements Gross
DebtIssuanceCostsLineOfCreditArrangementsGross
2400000 USD
CY2017Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1900000 USD
CY2018Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
3900000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
7582000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
9145000 USD
CY2017Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
56064000 USD
CY2018Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
46919000 USD
CY2017Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4500000 USD
CY2017Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4537000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
8954000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6718000 USD
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.57
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.58
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.00
CY2018Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3125000 USD
CY2018Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3100000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
6700000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
6718000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8954000 USD
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.98
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.76
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
89936000 USD
CY2018Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
87239000 USD
CY2017Q4 us-gaap Equity Method Investment Aggregate Cost
EquityMethodInvestmentAggregateCost
26400000 USD
CY2018Q2 us-gaap Equity Method Investment Aggregate Cost
EquityMethodInvestmentAggregateCost
29000000 USD
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
3416000 USD
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
2204000 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
30610000 USD
CY2018Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
31864000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-147000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-650000 USD
CY2017Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
121000000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
239600000 USD
CY2018Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
123100000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
244500000 USD
CY2017Q4 us-gaap Goodwill
Goodwill
319949000 USD
CY2018Q2 us-gaap Goodwill
Goodwill
324145000 USD
CY2017Q2 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
374946000 USD
CY2017Q2 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
374900000 USD
us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
739600000 USD
us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
739607000 USD
CY2018Q2 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
411603000 USD
CY2018Q2 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
411600000 USD
us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
810900000 USD
us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
810865000 USD
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2566000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
27688000 USD
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
44137000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
81020000 USD
CY2017Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2355000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2249000 USD
CY2018Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2976000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
4836000 USD
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1963000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7960000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
607000 USD
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
285000 shares
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2743000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4548000 USD
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10596000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20159000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
284000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
6149000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1093000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3623000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6833000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3604000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
2347000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1148000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-688000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6892000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
11680000 USD
CY2017Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
329000 shares
CY2018Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
425000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
381000 shares
CY2017Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
46061000 USD
CY2018Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
44888000 USD
CY2017Q2 us-gaap Interest Expense
InterestExpense
1197000 USD
us-gaap Interest Expense
InterestExpense
2265000 USD
CY2018Q2 us-gaap Interest Expense
InterestExpense
2140000 USD
us-gaap Interest Expense
InterestExpense
3843000 USD
us-gaap Interest Paid
InterestPaid
1172000 USD
us-gaap Interest Paid
InterestPaid
2080000 USD
CY2017Q2 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
41000 USD
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
60000 USD
CY2018Q2 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
114000 USD
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
234000 USD
CY2017Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
74943000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
149402000 USD
CY2018Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
77215000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
152846000 USD
CY2017Q4 us-gaap Liabilities
Liabilities
297056000 USD
CY2018Q2 us-gaap Liabilities
Liabilities
344263000 USD
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
813482000 USD
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
753324000 USD
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
215062000 USD
CY2018Q2 us-gaap Liabilities Current
LiabilitiesCurrent
214189000 USD
CY2018Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
550000000 USD
CY2017Q4 us-gaap Long Term Debt
LongTermDebt
88800000 USD
CY2018Q2 us-gaap Long Term Debt
LongTermDebt
124600000 USD
CY2017Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
78203000 USD
CY2018Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
123937000 USD
CY2017Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
10638000 USD
CY2018Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
668000 USD
CY2017Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
10600000 USD
CY2018Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
700000 USD
CY2017Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
78200000 USD
CY2018Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
123900000 USD
CY2017Q4 us-gaap Minority Interest
MinorityInterest
1105000 USD
CY2018Q2 us-gaap Minority Interest
MinorityInterest
1108000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2926000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-146226000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-31448000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5203000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
63341000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
90970000 USD
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
4461000 USD
us-gaap Net Income Loss
NetIncomeLoss
19591000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
33349000 USD
us-gaap Net Income Loss
NetIncomeLoss
60508000 USD
CY2017Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
68000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
137000 USD
CY2018Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
192000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
353000 USD
CY2017Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2326000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2283000 USD
CY2018Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1309000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2187000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 Segments
CY2018Q2 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
34 state
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
200000 USD
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
240000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
25400000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
25405000 USD
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
42828000 USD
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
42800000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
78800000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
78833000 USD
CY2017Q4 us-gaap Other Assets Current
OtherAssetsCurrent
16268000 USD
CY2018Q2 us-gaap Other Assets Current
OtherAssetsCurrent
24784000 USD
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
49130000 USD
CY2018Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
50601000 USD
CY2017Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
41617000 USD
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
82034000 USD
CY2018Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
42104000 USD
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
83784000 USD
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3791000 USD
CY2018Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6137000 USD
CY2017Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1127000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2239000 USD
CY2018Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
359000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
960000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
181402000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
2433000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
5726000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2832000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
24128000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
4074000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
436000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7449000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1611000 USD
us-gaap Pension Expense
PensionExpense
4367000 USD
us-gaap Pension Expense
PensionExpense
4894000 USD
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2018Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2018Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2018Q2 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2017Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7329000 USD
CY2018Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
10493000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
11000 USD
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
565000 USD
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
471000 USD
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0 USD
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
127500000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4203000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2609000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1187000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1157000 USD
CY2017Q2 us-gaap Profit Loss
ProfitLoss
4529000 USD
us-gaap Profit Loss
ProfitLoss
19728000 USD
CY2018Q2 us-gaap Profit Loss
ProfitLoss
33541000 USD
us-gaap Profit Loss
ProfitLoss
60861000 USD
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
177900000 USD
CY2018Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
129100000 USD
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31122000 USD
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31100000 USD
CY2018Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27998000 USD
CY2017Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1782367 shares
CY2018Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
4242820 shares
CY2017Q4 us-gaap Treasury Stock Value
TreasuryStockValue
53713000 USD
CY2018Q2 us-gaap Treasury Stock Value
TreasuryStockValue
237947000 USD
CY2017Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34329000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34203000 shares
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
90475000 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
204000 USD
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
60712000 USD
CY2017Q2 us-gaap Share Based Compensation
ShareBasedCompensation
4356000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
8230000 USD
CY2018Q2 us-gaap Share Based Compensation
ShareBasedCompensation
3767000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
7811000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
515321000 USD
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
407953000 USD
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
516426000 USD
CY2018Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
409061000 USD
CY2018Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28000000 USD
CY2017Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2500000 USD
CY2018Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34179000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34391000 shares
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33637000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33540000 shares
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33439000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33705000 shares
us-gaap Comparability Of Prior Year Financial Data
ComparabilityOfPriorYearFinancialData
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:24px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Reclassifications and Comparability</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain reclassifications have been made to prior periods&#8217; financial statements in order to conform to the current period&#8217;s presentation.</font></div></div>
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:24px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our accounting and reporting policies conform with U.S. GAAP. In preparing the unaudited condensed consolidated financial statements, we are required to make estimates and assumptions that impact the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name View Source Status
0000896262-18-000008-index-headers.html Edgar Link pending
0000896262-18-000008-index.html Edgar Link pending
0000896262-18-000008.txt Edgar Link pending
0000896262-18-000008-xbrl.zip Edgar Link pending
amed-20180630.xml Edgar Link completed
amed-20180630.xsd Edgar Link pending
amed-20180630_cal.xml Edgar Link unprocessable
amed-20180630_def.xml Edgar Link unprocessable
amed-20180630_lab.xml Edgar Link unprocessable
amed-20180630_pre.xml Edgar Link unprocessable
amed-20183006x10xq.htm Edgar Link pending
amed-20183006xexx101.htm Edgar Link pending
amed-20183006xexx311.htm Edgar Link pending
amed-20183006xexx312.htm Edgar Link pending
amed-20183006xexx321.htm Edgar Link pending
amed-20183006xexx322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image0.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending